These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 7523310)
1. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310 [TBL] [Abstract][Full Text] [Related]
2. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas. Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227 [TBL] [Abstract][Full Text] [Related]
3. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis. Matsunaga T; Shirasawa H; Enomoto H; Yoshida H; Iwai J; Tanabe M; Kawamura K; Etoh T; Ohnuma N Int J Cancer; 1998 Jun; 79(3):226-31. PubMed ID: 9645342 [TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening. Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804 [TBL] [Abstract][Full Text] [Related]
5. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993 [TBL] [Abstract][Full Text] [Related]
6. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage. Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211 [TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879 [TBL] [Abstract][Full Text] [Related]
8. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334 [TBL] [Abstract][Full Text] [Related]
9. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor. Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833 [TBL] [Abstract][Full Text] [Related]
11. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study. Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212 [TBL] [Abstract][Full Text] [Related]
12. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. Bjelfman C; Hedborg F; Johansson I; Nordenskjöld M; Påhlman S Cancer Res; 1990 Nov; 50(21):6908-14. PubMed ID: 1698545 [TBL] [Abstract][Full Text] [Related]
14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489 [TBL] [Abstract][Full Text] [Related]
16. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429 [TBL] [Abstract][Full Text] [Related]
17. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991 [TBL] [Abstract][Full Text] [Related]
18. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas. Hachitanda Y; Saito M; Mori T; Hamazaki M Med Pediatr Oncol; 1997 Aug; 29(2):135-8. PubMed ID: 9180916 [TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399 [TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Martinsson T; Sjöberg RM; Hedborg F; Kogner P Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]